Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Asset disposition
Appointed CFO
Quarterly results
Director departure
Appointed director
|
|
ARCA biopharma, Inc. (ABIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 5.3% stake in ARCA Biopharma, INC. |
| 06/10/2020 |
SC 13G
| Altium Capital Management LP reports a 10% stake in ARCA biopharma, Inc. |
| 06/01/2020 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in ARCA BIOPHARMA, INC. |
| 02/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2016 |
SC 13G
| Hambrecht & Quist Capital Management LLC reports a 811227% stake in ARCA biopharma, Inc. |
| 10/07/2013 |
SC 13G
| mccormack riley reports a 18.3% stake in ARCA biopharma, Inc. |
| 06/03/2013 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in ARCA Biopharma, Inc. |
| 08/08/2012 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 8.8% stake in ARCA Biopharma, Inc. |
| 04/28/2011 |
SC 13G
| ARCA biopharma, Inc. has filed a Schedule 13D for ARCA biopharma, Inc. |
| 04/28/2011 |
SC 13G
| ARCA biopharma, Inc. has filed a Schedule 13D for ARCA biopharma, Inc. |
| 02/16/2010 |
SC 13G
| ARCA biopharma, Inc. has filed a Schedule 13D for ARCA BIOPHARMA, INC. |
| 02/10/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/10/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/05/2009 |
SC 13G
| BOULDER VENTURES IV ANNEX LP has filed a Schedule 13D for ARCA biopharma, Inc. |
| 12/08/2008 |
SC 13G
| NUVELO INC reports a 7.9% stake in Nuvelo, Inc. |
|
|